NF-κB as a therapeutic target in neurodegenerative diseases
- 17 January 2007
- journal article
- review article
- Published by Informa Healthcare in Emerging Therapeutic Targets
- Vol. 11 (2) , 123-132
- https://doi.org/10.1517/14728222.11.2.123
Abstract
(2007). NF-κB as a therapeutic target in neurodegenerative diseases. Expert Opinion on Therapeutic Targets: Vol. 11, No. 2, pp. 123-132.Keywords
This publication has 101 references indexed in Scilit:
- NF-κB and IKK as therapeutic targets in cancerCell Death & Differentiation, 2006
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory TherapiesMolecular Interventions, 2002
- Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling PathwayScience, 2001
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of ApoptosisThe Journal of Experimental Medicine, 1999
- IKK-γ is an essential regulatory subunit of the IκB kinase complexNature, 1998
- Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB ActivationCell, 1998
- The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimersCell, 1993
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986